ArticleCancer cell international2020

Zoledronic acid inhibits TSC2-null cell tumor growth via RhoA/YAP signaling pathway in mouse models of lymphangioleiomyomatosis.

Dandan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.